Search results for "IMMUNIZATION"

showing 10 items of 313 documents

Educational Interventions on Pregnancy Vaccinations during Childbirth Classes Improves Vaccine Coverages among Pregnant Women in Palermo’s Province

2021

Maternal immunization is considered the best intervention in order to prevent influenza infection of pregnant women and influenza and pertussis infection of newborns. Despite the existing recommendations, vaccination coverage rates in Italy remain very low. Starting from August 2018, maternal immunization against influenza and diphtheria-tetanus-pertussis were strongly recommended by the Italian Ministry of Health. We conducted a cross sectional study to estimate the effectiveness of an educational intervention, conducted during childbirth classes in three general hospitals in the Palermo metropolitan area, Italy, on vaccination adherence during pregnancy. To this end, a questionnaire on kn…

PharmacologyImmunologydiphtheria-tetanus-pertussis vaccinationChildbirth courses Diphtheria-tetanus-pertussis vaccination Influenza vaccination Maternal immunization Vaccination counselingRSettore MED/42 - Igiene Generale E ApplicataArticleinfluenza vaccinationInfectious Diseasesmaternal immunization; influenza vaccination; diphtheria-tetanus-pertussis vaccination; childbirth courses; vaccination counselingDrug DiscoveryMedicinePharmacology (medical)vaccination counselingmaternal immunizationchildbirth coursesVaccines
researchProduct

The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and…

2022

Background: Research shows that in most people, two-dose vaccination helps to shape the humoral response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Further studies are required to learn about the vaccine’s effectiveness after boosting. Methods: We conducted a prospective study among 103 healthcare workers (HCWs) from a regional multi-specialty hospital vaccinated with three doses of the BNT162b2 vaccine. We compared their immunoglobulin G (IgG) titers 14 days after the second dose with those 21 days after the booster. We also compared their anthropometric and body composition parameters with IgG concentrations at the same time points. Results: Twenty-one days aft…

PharmacologyInfectious DiseasesDrug DiscoveryImmunologyPharmacology (medical)IgG antibody; SARS-CoV-2; COVID-19; healthcare workers; humoral response; COVID-19 vaccine; BNT162b2 vaccine; immunization; body composition; boosterVaccines; Volume 10; Issue 10; Pages: 1638
researchProduct

Sero-Epidemiological Study of Varicella in the Italian General Population.

2023

The aim of this study was to analyze the seroprevalence of varicella in Italy and to evaluate the impact of varicella vaccination, which has been mandatory for newborns since 2017. The levels of VZV-specific IgG antibodies were determined by the ELISA method in residual serum samples obtained from subjects aged between 6 and 64 years and residing in 13 Italian regions. Overall, 3746 serum samples were collected in the years 2019 and 2020. The overall seroprevalence was 91.6% (89.9% in males and 93.3% in females; p = 0.0002). Seroprevalence showed an increasing trend (p < 0.0001) starting in the younger age groups: 6–9 years: 84.1%; 10–14 years: 88.7%; 15–19 years: 89.3%…

PharmacologyInfectious DiseasesvaricellaItaly; general population; immunization; sero-epidemiology; varicellaItalysero-epidemiologyDrug DiscoveryImmunologyPharmacology (medical)immunizationSettore MED/42 - Igiene Generale E Applicatavaricella sero-epidemiology Italy general population immunizationgeneral population
researchProduct

COVID-19 Vaccination in Migrants and Refugees: Lessons Learnt and Good Practices.

2022

The COVID-19 pandemic has exacerbated inequalities between low- and high-income countries. Within the latter, a greater impact is seen in the poorest and most vulnerable people, including refugees, asylum seekers, and migrants. They all may experience poor access to quality healthcare or have suboptimal health-seeking behavior, distrust of governments, or fear of detention and deportation if seeking healthcare. Some refugees and migrants may face multiple barriers to vaccination and access to health systems that are relevant to the administration of COVID-19 vaccines, despite the growing inclusion of these populations in public health policies. Several good practices have emerged to ensure …

Pharmacologyhealth policieImmunologyCOVID-19global healthimmunizationSettore MED/42 - Igiene Generale E ApplicatamigrantInfectious Diseasesvulnerable groupsvaccineDrug DiscoveryPharmacology (medical)refugeeVaccines
researchProduct

Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical prac…

2022

Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016–2017 (DTaP3-IPV-HB/Hib) and 2018–2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of adm…

Pharmacologyvaccination coverage.ImmunologyVaccinationInfantPoliovirus Vaccine InactivatedChild PreschoolImmunology and AllergyHumansHepatitis B VaccinesPublic HealthVaccines CombinedHexavalent vaccineChildSicilyreal-life vaccinationDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleinterchangeabilityHaemophilus VaccinesRetrospective Studiesco-administration
researchProduct

Monitoring serologic response to single in ovo vaccination with an immune complex vaccine against infectious bursal disease in broilers

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S003257912100033X The infectious bursal disease (IBD) virus is one of the most resistant and prevalent virus worldwide in the poultry industry, being vaccination the main tool to control the disease. For this reason, consistent and uniform immunization of broiler flocks against IBD is necessary to avoid the disease spreading. The aim of this study was to apply and assess an epidemiologic mapping tool focused on the immunization by in ovo single broiler vaccination using an immune complex IBD vaccine. With this regard, 7,576 serum samples were collected from 603 broiler flocks raised …

Pollos - Inmunología.animal diseasesChickens - Vaccination.IBDAntigen-Antibody ComplexChick EmbryoAntibodies ViralIn ovobroilerInfectious bursal disease virusSerologyInfectious bursal diseaseGeoServerIMMUNOLOGY HEALTH AND DISEASEAnimalsMedicineSeroprevalenceAves de corral - Enfermedades.Poultry - Diseases.Pollos - Enfermedades.Poultry DiseasesOvumlcsh:SF1-1100business.industryViral VaccinesGeneral MedicineBirnaviridae Infectionsmedicine.diseasevaccinationVaccinationTiterImmunizationChickens - Diseases.ImmunologyChickens - Immunology.Animal Science and ZoologyELISAFlocklcsh:Animal culturePollos - Vacunación.businessChickens
researchProduct

Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemothera…

2003

Globally, Streptococcus pneumoniae is a leading cause of invasive and noninvasive disease in infants and young children. The emergence of antibiotic-resistant strains has increased interest in prevention through immunization. Currently, the only available conjugate pneumococcal vaccine is a seven-valent formulation, PNCRM7. This paper presents excerpts from a symposium that provided an update of ongoing surveillance data and clinical trials evaluating pneumococcal conjugate vaccines. The topics addressed included: (1) PNCRM7 postmarketing safety data; (2) the impact of PNCRM7 in premature infants; (3) the direct and indirect effect of pneumococcal conjugate vaccines on colonization; (4) the…

Potential impactChemotherapymedicine.medical_specialtyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industrymedicine.medical_treatmentPublic Health Environmental and Occupational HealthAntimicrobialmedicine.disease_causeClinical trialInfectious DiseasesPneumococcal vaccineImmunizationStreptococcus pneumoniaeImmunologyMolecular MedicineMedicinebusinessIntensive care medicineConjugateVaccine
researchProduct

Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa

2009

ABSTRACT B-cell activating factor (BAFF), a member of the TNF family, is a potent cytokine with stimulatory effects on B and T cells. To evaluate the potential of transient overexpression of BAFF to enhance vaccine immunogenicity, a replication-deficient adenovirus expressing full-length murine BAFF (AdBAFF) was tested in a mouse vaccine model against Pseudomonas aeruginosa . When coadministered with heat-killed P. aeruginosa , AdBAFF mediated a significant increase in anti- P. aeruginosa- specific serum and lung mucosal antibodies and resulted in improved protection against a lethal respiratory challenge with P. aeruginosa . This effect was independent of the site of administration of AdBA…

Pseudomonas Vaccinesmedicine.medical_treatmentGenetic VectorsImmunologyBiologymedicine.disease_causeMicrobiologyAdenoviridaeMicrobiologyMiceImmune systemAdjuvants ImmunologicImmunityB-Cell Activating FactorPneumonia BacterialmedicineAnimalsB-cell activating factorImmunity MucosalPseudomonas aeruginosaAntibodies BacterialSurvival AnalysisMice Inbred C57BLInfectious DiseasesCytokineVaccines InactivatedImmunizationMicrobial Immunity and VaccinesPseudomonas aeruginosaImmunologybiology.proteinFemaleParasitologyAntibodyAdjuvantInfection and Immunity
researchProduct

Mast cell-derived tumour necrosis factor is essential for allergic airway disease

2007

Mast cells are thought to contribute to allergic airway disease. However, the role of mast cell-produced mediators, such as tumour necrosis factor (TNF), for the development of allergic airway disease is unclear. In order to define the role of mast cells in acute allergic airway disease two strains of mast cell-deficient mice (Kit W/Wv and Kit W-sh/W-sh ) were studied. Compared with their wild-type littermates, Kit W/Wv and Kit W-sh/W-sh mice developed significantly lower airway responsiveness to methacholine and less airway inflammation and goblet cell metaplasia, following sensitisation in the absence of adjuvant and airway challenge. Transfer of bone marrow-derived mast cells (BMMCs) fro…

Pulmonary and Respiratory MedicineAllergyPathologymedicine.medical_specialtyNecrosisInflammationMiceMetaplasiamedicineAnimalsMast CellsInflammationMice KnockoutGoblet cellTumor Necrosis Factor-alphabusiness.industryAllergensrespiratory systemmedicine.diseaseMast cellAsthmarespiratory tract diseasesDisease Models Animalmedicine.anatomical_structureImmunologyImmunizationTumor necrosis factor alphaGoblet CellsBronchial Hyperreactivitymedicine.symptomAirwaybusinessEuropean Respiratory Journal
researchProduct

Factors associated with influenza vaccination of hospitalized elderly patients in Spain

2016

Vaccination of the elderly is an important factor in limiting the impact of influenza in the com- munity. The aim of this study was to investigate the factors associated with influenza vacci- nation coverage in hospitalized patients aged 65 years hospitalized due to causes unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking in to account sociodemographic variables and medical risk conditions. Multivariate analysis was per- formed using multilevel regression models. We included 1038 patients: 602 (58%) had received the influenza vaccine in the 2013 - 14 season. Three or more general p…

RNA virusesMaleViral Diseaseslcsh:MedicineGlobal HealthPersones gransGeographical LocationsPneumococcal VaccinesElderlyMedicine and Health SciencesPublic and Occupational HealthVacunaciólcsh:SciencePathology and laboratory medicineAged 80 and overVaccinesVaccinationMedical microbiologyVaccination and ImmunizationEuropeInfectious DiseasesStreptococcus pneumoniaeInfluenza A virusInfluenza VaccinesVirusesFemalePathogensAssistència hospitalàriaResearch ArticleImmunologyMicrobiologyInfluenzavirusPatient Education as TopicInfluenza HumanHumansInfluenza virusesEspanyaAgedInpatientsHospital careMarital Statuslcsh:ROrganismsViral pathogensBiology and Life SciencesPneumonia PneumococcalInfluenzaMicrobial pathogensCross-Sectional StudiesSocial ClassAge GroupsSpainPeople and PlacesPopulation Groupingslcsh:QPreventive MedicineOlder peopleOrthomyxoviruses
researchProduct